Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
Condition(s):Renal Cell CarcinomaLast Updated:November 21, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:November 21, 2013Completed
Condition(s):Cystic Renal Diseases; Kidney NeoplasmsLast Updated:August 28, 2019Completed
Condition(s):Renal Vascular Disease; Nutcracker Syndrome, Renal; Pelvic Trauma; Loin Pain-Hematuria Syndrome; Renal Tumor; Congestion, VenousLast Updated:December 22, 2022Enrolling by invitation
Condition(s):Kidney Failure; Hypertension; Albuminuria; Renal Failure; Inflammation; Endothelial DysfunctionLast Updated:March 29, 2012Completed
Condition(s):Kidney Failure, Chronic; Kidney Transplantation; ImmunosuppressionLast Updated:January 2, 2017Completed
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:October 6, 2023Recruiting
Condition(s):Intraoperative Flow DisruptionsLast Updated:April 13, 2022Completed
Condition(s):Complications, PostoperativeLast Updated:April 28, 2022Not yet recruiting
Condition(s):End Stage Renal DiseaseLast Updated:July 24, 2014Unknown status
Condition(s):Hypothermia; Anesthesia; Anesthesia; Adverse Effect; Peroperative Complication; Postoperative Complications; Surgical Site Infection; Temperature Change, BodyLast Updated:July 9, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.